{"id":"https://genegraph.clinicalgenome.org/r/b7bc5a97-d0f6-4160-80c4-8976fa0b7544v1.0","type":"EvidenceStrengthAssertion","dc:description":"The *TRAPPC6B* gene is located on chromosome 14 at 14q21.1 and encodes the trafficking protein particle complex, subunit 6B  protein, a core subunit of TRAPP II and TRAPP III complexes. *TRAPPC6B* was first reported in relation to autosomal recessive neurodevelopmental disorder with microcephaly, epilepsy and brain atrophy (NEDMEBA) in 2018 (Marin-Valencia et al., PMID: 28626029). NEDMEBA is characterized by severe intellectual disability, global developmental delay, microcephaly and short stature. Evidence supporting this gene-disease relationship includes case-level data, segregation data and experimental evidence. To date, 6 splice site variants and 9 nonsense variants, including 10 unique and 5 recurrent variants in 38 patients have been reported in four publications. Two splice site variants and 4 nonsense variants from four publications are included in this curation (PMID 28626029, 28397838, 31687267, 37713627). This gene-disease relationship is supported by experimental evidence including functional alteration and rescue in patient cells, as well as data from zebrafish and drosophila models showing partial recapitulation of phenotype (PMID 37713627, 28626029). In summary, there is definitive evidence to support the relationship between *TRAPPC6B* and autosomal recessive NEDMEBA. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date November 19, 2024 (SOP Version 11).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b7bc5a97-d0f6-4160-80c4-8976fa0b7544","GCISnapshot":"https://genegraph.clinicalgenome.org/r/b98a9fbd-43ee-460c-8e22-0f2d31309b82","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/b98a9fbd-43ee-460c-8e22-0f2d31309b82_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-11-19T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/b98a9fbd-43ee-460c-8e22-0f2d31309b82_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2025-01-07T15:28:35.202Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b98a9fbd-43ee-460c-8e22-0f2d31309b82_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b98a9fbd-43ee-460c-8e22-0f2d31309b82_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6dad66df-7efe-43e4-90fe-529600923aa7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28626029","rdfs:label":"Marin-Valencia_Family 1712","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/6dad66df-7efe-43e4-90fe-529600923aa7","type":"Family","rdfs:label":"Marin-Valencia_Family 1712","member":{"id":"https://genegraph.clinicalgenome.org/r/9e3e3494-7529-45b4-a362-3e9fdda564b1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28626029","rdfs:label":"1712-3-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/b4fbe9cb-6eb0-419e-b810-5dc72d0acc19","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079537.2(TRAPPC6B):c.82-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7162867"}},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4b0ed8e8-9cd1-43a4-a311-bbc38e71d836_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28626029","allele":{"id":"https://genegraph.clinicalgenome.org/r/b4fbe9cb-6eb0-419e-b810-5dc72d0acc19"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001252","obo:HP_0001263","obo:HP_0004322","obo:HP_0000252","obo:HP_0100023","obo:HP_0002194"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9e3e3494-7529-45b4-a362-3e9fdda564b1"}},{"id":"https://genegraph.clinicalgenome.org/r/9d27be1c-fcca-4ce5-ac77-f1d0fe92835f_family_segregation","type":"FamilyCosegregation","dc:description":"WES analysis of each affected member from family 341 and 350 detected a homozygous mutation in a putative, well-conserved splice site in TRAPPC6B, falling in a linkage peak with LOD>2 identified in both families. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28626029","rdfs:label":"Marin-Valencia_Family 341","estimatedLodScore":1.1,"family":{"id":"https://genegraph.clinicalgenome.org/r/9d27be1c-fcca-4ce5-ac77-f1d0fe92835f","type":"Family","rdfs:label":"Marin-Valencia_Family 341","ethnicity":{"id":"cg:UnknownEthnicity"}},"meetsInclusionCriteria":true,"phenotype":[{"id":"obo:HP_0100023"},{"id":"obo:HP_0002194"},{"id":"obo:HP_0004322"},{"id":"obo:HP_0001263"},{"id":"obo:HP_0001344"},{"id":"obo:HP_0001252"},{"id":"obo:HP_0031165"},{"id":"obo:HP_0000252"}],"phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":2,"publishedLodScore":2,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/1b3f2091-a004-462d-bbec-b95f617dc6ac_family_segregation","type":"FamilyCosegregation","dc:description":"WES analysis of each affected member from family 341 and 350 detected a homozygous mutation in a putative, well-conserved splice site in TRAPPC6B, falling in a linkage peak with LOD>2 identified in both families.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28626029","rdfs:label":"Marin-Valencia_Family 350","estimatedLodScore":1.1,"family":{"id":"https://genegraph.clinicalgenome.org/r/1b3f2091-a004-462d-bbec-b95f617dc6ac","type":"Family","rdfs:label":"Marin-Valencia_Family 350"},"meetsInclusionCriteria":true,"phenotype":[{"id":"obo:HP_0002194"},{"id":"obo:HP_0001263"},{"id":"obo:HP_0100023"},{"id":"obo:HP_0004322"},{"id":"obo:HP_0000252"},{"id":"obo:HP_0031165"},{"id":"obo:HP_0001252"}],"phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":2,"publishedLodScore":2,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b2f666a5-cb72-407b-a34b-799d674ae5a8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bf6fdc6-9fe6-49a4-884b-dba90e024505","type":"EvidenceLine","dc:description":"Downgraded as it is homozygous variant in consanguineous family","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bf6fdc6-9fe6-49a4-884b-dba90e024505_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37713627","allele":{"id":"https://genegraph.clinicalgenome.org/r/c4b20c02-dc24-473a-9602-7400ed6170ff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079537.2(TRAPPC6B):c.149+2T>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7162853"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/b2f666a5-cb72-407b-a34b-799d674ae5a8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37713627","rdfs:label":"Almousa_Patient 5 (Family 4)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c4b20c02-dc24-473a-9602-7400ed6170ff"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001263","obo:HP_0000252"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0bf6fdc6-9fe6-49a4-884b-dba90e024505_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/9e3e3494-7529-45b4-a362-3e9fdda564b1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b0ed8e8-9cd1-43a4-a311-bbc38e71d836","type":"EvidenceLine","dc:description":"Downgraded as it is homozygous variant in consanguineous family","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b0ed8e8-9cd1-43a4-a311-bbc38e71d836_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dermal fibroblast from affected individuals showed an abnormal shorter transcript (figure 1E). DNA from PCR bands was extracted for sequencing, which confirmed that the shorter transcript skipped exon 2, leading to a reading frameshift and protein truncation (figure 1E).","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/4b0ed8e8-9cd1-43a4-a311-bbc38e71d836_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/9e3e3494-7529-45b4-a362-3e9fdda564b1"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/ac0d8a62-8ea9-4983-975a-884d5c2499c0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53fda9ea-8aa5-48ae-9059-cee236e3b2c0","type":"EvidenceLine","dc:description":"Downgraded as it is homozygous variant in consanguineous family","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53fda9ea-8aa5-48ae-9059-cee236e3b2c0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28397838","allele":{"id":"https://genegraph.clinicalgenome.org/r/cd9293a3-3a49-4ddc-9c0e-759719f756ba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079537.2(TRAPPC6B):c.124C>T (p.Arg42Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7162858"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/ac0d8a62-8ea9-4983-975a-884d5c2499c0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28397838","rdfs:label":"IDH3","allele":{"id":"https://genegraph.clinicalgenome.org/r/cd9293a3-3a49-4ddc-9c0e-759719f756ba"},"firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0001249","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/53fda9ea-8aa5-48ae-9059-cee236e3b2c0_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/1e06c2f7-4f66-461e-ae1a-639f1f8aadfe_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77957adc-d903-4185-943a-4fc78bb8236a","type":"EvidenceLine","dc:description":"Downgraded as it is homozygous variant in consanguineous family","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77957adc-d903-4185-943a-4fc78bb8236a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31687267","allele":{"id":"https://genegraph.clinicalgenome.org/r/479d0c35-684b-4c2a-b5c9-1b55cc61453f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079537.2(TRAPPC6B):c.23T>A (p.Leu8Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389538172"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/1e06c2f7-4f66-461e-ae1a-639f1f8aadfe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31687267","rdfs:label":"Patient 8","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/479d0c35-684b-4c2a-b5c9-1b55cc61453f"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001249","obo:HP_0000252","obo:HP_0001252"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/77957adc-d903-4185-943a-4fc78bb8236a_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/7931c07f-b24c-4997-bea1-f661f2fe31a3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/434d005c-ce90-4a8f-9d91-3970028a714b","type":"EvidenceLine","dc:description":"Downgraded as it is homozygous variant in consanguineous family","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/434d005c-ce90-4a8f-9d91-3970028a714b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Decreased in several TRAPPC6B protein levels observed in patient's fibroblast. Several TRAPP protein levels were decreased, with strongest effect seen in TRAPPC10 and TRAPPC9. Both are TRAPP II-specific proteins (Figure 3C).","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/434d005c-ce90-4a8f-9d91-3970028a714b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37713627","allele":{"id":"https://genegraph.clinicalgenome.org/r/cf109f50-7481-47b9-86d9-c2490ea65a1f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079537.2(TRAPPC6B):c.454C>T (p.Gln152Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389550203"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/7931c07f-b24c-4997-bea1-f661f2fe31a3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37713627","rdfs:label":"Almousa_Patient 23 (Family 15)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/cf109f50-7481-47b9-86d9-c2490ea65a1f"},"firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0001263","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/434d005c-ce90-4a8f-9d91-3970028a714b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/9eaafd59-d0dd-4862-9020-ce8530e3a4dd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8625fabf-70d2-469c-865f-63e16026e882","type":"EvidenceLine","dc:description":"Downgraded as it is homozygous variant in consanguineous family","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8625fabf-70d2-469c-865f-63e16026e882_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37713627","allele":{"id":"https://genegraph.clinicalgenome.org/r/5f8e5052-2a5f-4e39-be51-b55135fa8faf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079537.2(TRAPPC6B):c.91C>T (p.Arg31Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389554365"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/9eaafd59-d0dd-4862-9020-ce8530e3a4dd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37713627","rdfs:label":"Almousa_Patient 3 (Family 2)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5f8e5052-2a5f-4e39-be51-b55135fa8faf"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000252","obo:HP_0001263"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8625fabf-70d2-469c-865f-63e16026e882_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/b98a9fbd-43ee-460c-8e22-0f2d31309b82_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b98a9fbd-43ee-460c-8e22-0f2d31309b82_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf3c0e40-ad72-4564-8ade-495571db8931","type":"EvidenceLine","dc:description":"Downgraded as it is not mouse model","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fa21830-11bf-480c-88d2-f522be0b574a","type":"Finding","dc:description":"Trappc6b-atg morphants manifested decreased survival rate, and both the trappc6b-atg and the trappc6b-splice morphants had reduced head size but normal body length (Figure 2A-B). Also, trappc6b morphants manifested a significant increase in spontaneous neuronal firing, as well as increased activity in response to low dose of PTZ (figure 2C-E). Altogether, trappc6b disruption in zebrafish impairs brain growth, leads to neuronal hyperexcitability and lowers seizure threshold. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28626029","rdfs:label":"TRAPPC6B zebrafish model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0c5bd9f5-1f85-435e-bff2-340ff429c885","type":"EvidenceLine","dc:description":"Downgraded as it is not mouse model","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4ca5bf6-e1df-4b86-b6c9-9598f932c86d","type":"Finding","dc:description":"Flight muscle weakness in Drosophila model has similarities to the postural/locomotor impairments in TRAPPC6B-affected individuals","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37713627","rdfs:label":"Neuronal TRAPPC6B knockdown impairments in Drosophila","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/999c3674-7ec9-40dc-b862-9ec6b68f1ce7","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/891d8c54-d6a8-4118-9642-39d20f020996","type":"Finding","dc:description":"Trafficking defect of ER-retained protein to Golgi was rescue in the transfected cells (Fig 5A and B). Golgi fragmentation was rescued to near wild-type levels (Fig 5C and D).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37713627","rdfs:label":"Rescue of ER-Golgi trafficking defects in patient cells","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/b98a9fbd-43ee-460c-8e22-0f2d31309b82_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/904361e4-d54d-4a96-a611-bab6840fa8b0","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7cd13c70-594f-43dd-96e6-5bae3d631422","type":"FunctionalAlteration","dc:description":"Fibroblast derived from families 4 (c.149+2T>A splice site; patient 5 and 6) and 15 (p.Q152*, patient 23 and 24) were subjected to membrane trafficking assay. Upon biotin-mediated release of ER-retained protein in membrane trafficking assay, there was delay in transport to the Golgi compared to control  (Fig 5A and B). Also, a significant increase in Golgi fragmentation was seen (Fig 5C and D).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37713627","rdfs:label":"ER-Golgi trafficking defects in patient cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b98a9fbd-43ee-460c-8e22-0f2d31309b82_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/518ff185-f46f-4a2a-aefb-b16553e617dd","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba17fa25-f599-4b48-9480-5c44b03c550e","type":"Finding","dc:description":"HeLa cells were either untransfected (NT) or co-transfected with\nTRAPPC6A-V5/TRAPPC10-FLAG, TRAPPC6A-V5/TRAPPC11-FLAG, TRAPPC6B-V5/TRAPPC10-FLAG or TRAPPC6B-V5/TRAPPC11, and subject to immunoprecipitation. Quantification experiment was performed. Unlike TRAPPC6A, which equally co-precipitated with TRAPPC10 and TRAPPC11, TRAPPC6B was significantly more enriched with TRAPPC10 compared to TRAPPC11 (Fig. 4B). These results suggest that TRAPP II complexes are enriched in TRAPPC6B compared to TRAPP III.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37713627","rdfs:label":"TRAPPC6B association with TRAPP complex","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Definitive","sequence":9733,"specifiedBy":"GeneValidityCriteria11","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/R-ebwSElJmI","type":"GeneValidityProposition","disease":"obo:MONDO_0060640","gene":"hgnc:23066","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_b98a9fbd-43ee-460c-8e22-0f2d31309b82-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}